Golijaninet al. (29) found that CK20 ICC was effective in detecting tumors in 50% (n=87) of patients, with a sensitivity of 81.6%, specificity of 77%, and accuracy of 80%. This evidence concerns the gene KRT20 and intrahepatic cholangiocarcinoma.